Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil

被引:22
|
作者
Scotta, Marcelo Comerlato [1 ]
Paternina-de la Ossa, Rolando [1 ]
Lumertz, Magali Santos [1 ]
Jones, Marcus Herbert [1 ]
Mattiello, Rita [1 ]
Pinto, Leonardo Araujo [1 ]
机构
[1] Pontificia Univ Catolica Rio Grande Sul PUCRS, Dept Pediat, Sch Med, Ctr Infant, Ave Ipiranga 6690,2nd Floor, BR-90610000 Porto Alegre, RS, Brazil
关键词
Chickenpox; Varicella; Herpes zoster; Shingles; Hospitalizations; Child; UNITED-STATES; CLINICAL CHARACTERISTICS; COST-EFFECTIVENESS; ANTELOPE VALLEY; CHILDREN; IMPLEMENTATION; EPIDEMIOLOGY; PROGRAM; GERMANY; SPAIN;
D O I
10.1016/j.vaccine.2017.11.057
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The Brazilian childhood National Immunization Program (NIP) introduced live and attenuated varicella vaccination in a single dose, combined as tetraviral vaccine, at 15 months of age in the whole country, during September to December of 2013. The aim of this study was to report trends in incidence of childhood hospital admissions related to varicella and zoster in Brazil from 2003 to 2016, including the first three years after vaccine introduction. Methods: The number and incidence of hospital admission in patients aged less than 20 years in Brazilian public health system with an admission diagnosis of varicella and zoster from 2003 to 2016 were analyzed and pre (2003-2013) and post-vaccination periods (2014-2016) were compared. The data were obtained from DATASUS, a Brazilian government's open-access public health database system, and analyzed adjusting for secular trend and seasonality if a statistically significant change was found. Results: During the study period, 69,791 admissions due to varicella and herpes zoster occurred in the children younger than 20 years. After adjusting for seasonality, the incidence of hospitalizations decreased from 27.33 to 14.33 per 100000 per year, which corresponds to a reduction of 47.6% (95% confidence interval 18.19-77.04%, p < 0.001) in the vaccinated age group (1-4 years) in 2014-2016 compared to pre-vaccination period. The changes were not significant in the unvaccinated age groups. Conclusion: The hospitalizations due to varicella and herpes zoster were decreased by half early after the introduction of a single dose of tetraviral vaccine in NIP in the vaccinated children. Further studies may assess duration and intensity of this effect, as well as the indirect effect in the unvaccinated age groups. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 50 条
  • [31] The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics
    Suh, Jiyeon
    Lee, Taeyong
    Choi, Jae-Ki
    Lee, Jeehyun
    Park, Sun Hee
    VACCINE, 2021, 39 (18) : 2575 - 2583
  • [32] Effects of varicella vaccination on herpes zoster incidence
    Wagenpfeil, S
    Neiss, A
    Wutzler, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (11) : 954 - 960
  • [33] Economic Evaluation of Universal Varicella Vaccination in Mexico
    Chacon-Cruz, Enrique
    Meroc, Estelle
    Costa-Clemens, Sue Ann
    Clemens, Ralf
    Verstraeten, Thomas
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (05) : 439 - 444
  • [34] The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
    Christophe Sauboin
    Katsiaryna Holl
    Paolo Bonanni
    Anne A. Gershon
    Bernd Benninghoff
    Stephane Carryn
    Margaret A. Burgess
    Peter Wutzler
    BMC Infectious Diseases, 19
  • [35] The epidemiology of varicella and herpes zoster in The Netherlands:: Implications for varicella zoster virus vaccination
    de Melker, Hester
    Berbers, Guy
    Hahne, Susan
    Rumke, Hans
    van den Hof, Susan
    de Wit, Ardine
    Boot, Hein
    VACCINE, 2006, 24 (18) : 3946 - 3952
  • [36] Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study
    Monica Betta
    Alberto Landi
    Piero Manfredi
    Marco Laurino
    Medical & Biological Engineering & Computing, 2019, 57 : 1121 - 1132
  • [37] Global impact of varicella vaccination programs
    Varela, Fernanda Hammes
    Pinto, Leonardo Araujo
    Scotta, Marcelo Comerlato
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 645 - 657
  • [38] Routine varicella vaccination program and hospitalization for herpes zoster in Japan
    Kuniyoshi, Yasutaka
    Tokutake, Haruka
    Takahashi, Natsuki
    Kamura, Azusa
    Yasuda, Sumie
    Tashiro, Makoto
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4171 - 4176
  • [39] Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
    Goldman, G. S.
    King, P. G.
    VACCINE, 2013, 31 (13) : 1680 - 1694
  • [40] Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster
    Shiraki, Kimiyasu
    Toyama, Nozomu
    Tanaka, Keiko
    Ito, Akiko
    Yamamoto, Junko
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 104 (03) : 185 - 192